Analyst Consensus ?
ConsensusBuy38 ratings
Bullish2771.1%
Neutral1128.9%
Bearish00.0%
FN2 Earnings Intelligence
Elevance Health Inc. analyst ratings
Elevance Health Inc. (ELV) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$385.73Previous close
$320Low
$468.44Average
$625High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Leerink Partners | Market Perform | Market Perform | Maintain | Jul 17, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 16, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 16, 2026 |
| Guggenheim | Buy | Buy | Maintain | Jul 16, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 16, 2026 |
| Baird | Neutral | Neutral | Maintain | Jul 16, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 14, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 14, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 7, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jul 2, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jun 8, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jun 8, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 4, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jun 4, 2026 |
| UBS | Buy | Buy | Maintain | May 22, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | May 20, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Apr 23, 2026 |
| Jefferies | Buy | Buy | Maintain | Apr 20, 2026 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jan 8, 2026 |
| Argus Research | Hold | Buy | Downgrade | Jul 21, 2025 |
| Stephens & Co. | Overweight | Overweight | Maintain | Sep 5, 2024 |
| Loop Capital | Buy | Buy | Maintain | Apr 21, 2023 |
| SVB Leerink | Outperform | Outperform | Maintain | Jan 26, 2023 |
| BMO Capital | Outperform | Outperform | Maintain | Apr 25, 2022 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 21, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Apr 21, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Apr 14, 2021 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | May 21, 2020 |
| CFRA | Buy | Hold | Upgrade | Apr 29, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Dec 6, 2019 |
| Citigroup | Neutral | Neutral | Maintain | Nov 6, 2018 |
| PiperJaffray | Overweight | Neutral | Upgrade | Jan 3, 2018 |
| Leerink Swann | Outperform | Outperform | Maintain | Nov 7, 2017 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Jan 4, 2017 |
| FBR Capital | Market Perform | Market Perform | Maintain | Jan 28, 2016 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Jul 27, 2015 |
| Susquehanna | Positive | Positive | Maintain | May 22, 2015 |
| Oppenheimer | Outperform | Outperform | Maintain | May 1, 2015 |
Named analyst price targets
Upside is calculated against the persisted previous close $385.73. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Leerink Partners | Analyst unavailable | $395 | $369.28 | +2.4% | Jul 17, 2026 |
| Bernstein | Analyst unavailable | $488 | $372.85 | +26.5% | Jul 16, 2026 |
| New Street | Analyst unavailable | $482 | $377.63 | +25.0% | Jul 16, 2026 |
| RBC Capital | Analyst unavailable | $424 | $390.33 | +9.9% | Jul 16, 2026 |
| Goldman Sachs | Analyst unavailable | $395 | $390.33 | +2.4% | Jul 16, 2026 |
| Robert W. Baird | Analyst unavailable | $393 | $390.33 | +1.9% | Jul 16, 2026 |
| Guggenheim | Analyst unavailable | $455 | $390.33 | +18.0% | Jul 16, 2026 |
| Wells Fargo | Stephen Baxter | $473 | $390.33 | +22.6% | Jul 16, 2026 |
| Barclays | Analyst unavailable | $457 | $390.33 | +18.5% | Jul 16, 2026 |
| Truist Financial | Analyst unavailable | $475 | $425.17 | +23.1% | Jul 14, 2026 |
| Wells Fargo | Analyst unavailable | $492 | $416.23 | +27.6% | Jul 13, 2026 |
| RBC Capital | Ben Hendrix | $439 | $425.9 | +13.8% | Jul 9, 2026 |
| Raymond James | Sarah James | $450 | $408.17 | +16.7% | Jul 7, 2026 |
| Bernstein | Analyst unavailable | $482 | $416.19 | +25.0% | Jul 2, 2026 |
| Mizuho Securities | Analyst unavailable | $465 | $415.53 | +20.6% | Jun 8, 2026 |
| Morgan Stanley | Analyst unavailable | $404 | $391.27 | +4.7% | Jun 4, 2026 |
| Truist Financial | David MacDonald | $450 | $393.19 | +16.7% | Jun 1, 2026 |
| Barclays | Andrew Mok | $480 | $386.87 | +24.4% | May 26, 2026 |
| UBS | Analyst unavailable | $460 | $389.82 | +19.3% | May 22, 2026 |
| Mizuho Securities | Analyst unavailable | $435 | $402.27 | +12.8% | May 20, 2026 |
| Deutsche Bank | Analyst unavailable | $498 | $402.27 | +29.1% | May 20, 2026 |
| Guggenheim | Analyst unavailable | $399 | $346.29 | +3.4% | Apr 24, 2026 |
| Barclays | Analyst unavailable | $408 | $346.29 | +5.8% | Apr 24, 2026 |
| Leerink Partners | Analyst unavailable | $364 | $346.21 | -5.6% | Apr 23, 2026 |
| Robert W. Baird | Analyst unavailable | $331 | $328.2 | -14.2% | Apr 23, 2026 |
| Jefferies | David Windley | $391 | $323.05 | +1.4% | Apr 20, 2026 |
| Mizuho Securities | Ann Hynes | $350 | $282.68 | -9.3% | Mar 10, 2026 |
| RBC Capital | Analyst unavailable | $358 | $341.83 | -7.2% | Feb 3, 2026 |
| Truist Financial | Analyst unavailable | $390 | $341.28 | +1.1% | Feb 2, 2026 |
| Craig-Hallum | Analyst unavailable | $409 | $340.68 | +6.0% | Feb 2, 2026 |
| Bernstein | Analyst unavailable | $409 | $345.74 | +6.0% | Feb 1, 2026 |
| Wells Fargo | Analyst unavailable | $391 | $346.98 | +1.4% | Jan 30, 2026 |
| Barclays | Analyst unavailable | $393 | $346.98 | +1.9% | Jan 30, 2026 |
| UBS | Analyst unavailable | $400 | $345.27 | +3.7% | Jan 29, 2026 |
| Deutsche Bank | Analyst unavailable | $332 | $345.22 | -13.9% | Jan 29, 2026 |
| Guggenheim | Jason Cassorla | $396 | $341.85 | +2.7% | Jan 29, 2026 |
| Guggenheim | Jason Cassorla | $414 | $369.88 | +7.3% | Jan 22, 2026 |
| Mizuho Securities | Ann Hynes | $413 | $374.77 | +7.1% | Jan 9, 2026 |
| Wolfe Research | Justin Lake | $425 | $366.69 | +10.2% | Jan 8, 2026 |
| Wells Fargo | Analyst unavailable | $424 | $371.37 | +9.9% | Jan 7, 2026 |
| Bernstein | Analyst unavailable | $431 | $368.52 | +11.7% | Jan 6, 2026 |
| Barclays | Andrew Mok | $404 | $354.25 | +4.7% | Jan 5, 2026 |
| Deutsche Bank | George Hill | $320 | $344.6 | -17.0% | Dec 19, 2025 |
| Morgan Stanley | Analyst unavailable | $352 | $345.96 | -8.7% | Dec 18, 2025 |
| Mizuho Securities | Analyst unavailable | $400 | $313.19 | +3.7% | Nov 3, 2025 |
| Barclays | Analyst unavailable | $385 | $340.76 | -0.2% | Oct 22, 2025 |
| Bernstein | Analyst unavailable | $420 | $348.48 | +8.9% | Oct 21, 2025 |
| Truist Financial | Analyst unavailable | $400 | $348.16 | +3.7% | Oct 14, 2025 |
| Morgan Stanley | Erin Wright | $359 | $349.16 | -6.9% | Oct 14, 2025 |
| Goldman Sachs | Analyst unavailable | $343 | $351.42 | -11.1% | Oct 14, 2025 |
| Mizuho Securities | Analyst unavailable | $420 | $362.34 | +8.9% | Oct 9, 2025 |
| Barclays | Analyst unavailable | $395 | $362.34 | +2.4% | Oct 9, 2025 |
| Guggenheim | Analyst unavailable | $398 | $357.49 | +3.2% | Oct 8, 2025 |
| Wells Fargo | Stephen Baxter | $412 | $349.94 | +6.8% | Oct 7, 2025 |
| Truist Financial | David MacDonald | $500 | $389.61 | +29.6% | Jun 9, 2025 |
| Argus Research | Analyst unavailable | $465 | $421.68 | +20.6% | Apr 25, 2025 |
| Jefferies | David Windley | $529 | $430.77 | +37.1% | Oct 21, 2024 |
| Leerink Partners | Whit Mayo | $515 | $430.77 | +33.5% | Oct 21, 2024 |
| Raymond James | Sarah James | $485 | $432.53 | +25.7% | Oct 18, 2024 |
| RBC Capital | Ben Hendrix | $478 | $444.35 | +23.9% | Oct 18, 2024 |
| Truist Financial | David MacDonald | $520 | $444.35 | +34.8% | Oct 18, 2024 |
| Robert W. Baird | Michael Ha | $625 | $483.87 | +62.0% | Oct 16, 2024 |
| RBC Capital | Ben Hendrix | $585 | $502.06 | +51.7% | Jul 18, 2024 |
| Truist Financial | David MacDonald | $620 | $535.54 | +60.7% | Jul 15, 2024 |
| Morgan Stanley | Erin Wright | $643 | $534.42 | +66.7% | Jun 24, 2024 |
| Robert W. Baird | Michael Ha | $649 | $505.52 | +68.3% | May 29, 2024 |
| RBC Capital | Ben Hendrix | $575 | $525.19 | +49.1% | Apr 19, 2024 |
| UBS | AJ Rice | $605 | $525.19 | +56.8% | Apr 19, 2024 |
| Wells Fargo | Stephen Baxter | $600 | $525.19 | +55.5% | Apr 19, 2024 |
| Jefferies | David Windley | $604 | $525.19 | +56.6% | Apr 19, 2024 |
| Barclays | Andrew Mok | $621 | $525.19 | +61.0% | Apr 19, 2024 |
| Mizuho Securities | Analyst unavailable | $575 | $521.88 | +49.1% | Nov 10, 2022 |
| Loop Capital Markets | Joseph France | $550 | $454.76 | +42.6% | Jun 16, 2022 |
| Wells Fargo | Stephen Baxter | $580 | $501.53 | +50.4% | May 25, 2022 |
| BMO Capital | Analyst unavailable | $625 | $495.61 | +62.0% | Apr 25, 2022 |
| Deutsche Bank | Analyst unavailable | $574 | $510.4 | +48.8% | Apr 22, 2022 |
| Morgan Stanley | Analyst unavailable | $607 | $528.45 | +57.4% | Apr 21, 2022 |
| Goldman Sachs | Analyst unavailable | $605 | $529.84 | +56.8% | Apr 21, 2022 |
| Leerink Partners | Analyst unavailable | $555 | $529.84 | +43.9% | Apr 21, 2022 |
| Credit Suisse | Jonathan Yong | $584 | $522.87 | +51.4% | Apr 21, 2022 |
| RBC Capital | Ben Hendrix | $544 | $522.87 | +41.0% | Apr 21, 2022 |
| Evercore ISI | Michael Newshel | $335 | $529.84 | -13.2% | Apr 20, 2022 |
| Mizuho Securities | Ann Hynes | $510 | $529.84 | +32.2% | Apr 20, 2022 |
| Jefferies | David Windley | $625 | $529.84 | +62.0% | Apr 20, 2022 |
| Truist Financial | David MacDonald | $590 | $510.64 | +53.0% | Apr 11, 2022 |
| UBS | Kevin Caliendo | $541 | $489.34 | +40.3% | Apr 4, 2022 |
| J.P. Morgan | Lisa Gill | $500 | $434.61 | +29.6% | Jan 27, 2022 |
| BMO Capital | Matthew Borsch | $510 | $434.61 | +32.2% | Jan 27, 2022 |
| RBC Capital | Ben Hendrix | $452 | $434.61 | +17.2% | Jan 27, 2022 |
| Seaport Global | Joseph France | $480 | $427.24 | +24.4% | Jan 26, 2022 |
| Evercore ISI | Michael Newshel | $335 | $427.24 | -13.2% | Jan 26, 2022 |
| Bernstein | Lance Wilkes | $574 | $452.46 | +48.8% | Jan 11, 2022 |
| Wells Fargo | Steve Baxter | $523 | $438.22 | +35.6% | Jan 6, 2022 |
| Goldman Sachs | Nathan Rich | $517 | $432.72 | +34.0% | Dec 14, 2021 |
| Wolfe Research | Justin Lake | $433 | $403.96 | +12.3% | Nov 30, 2021 |
| Credit Suisse | A.J. Rice | $486 | $428 | +26.0% | Oct 21, 2021 |
| Barclays | Steven Valiquette | $485 | $428 | +25.7% | Oct 21, 2021 |
| Bank of America Securities | Kevin Fischbeck | $465 | $428 | +20.6% | Oct 21, 2021 |
| Cantor Fitzgerald | Steven Halper | $470 | $421.68 | +21.8% | Oct 20, 2021 |
Track every rating change on ELV the moment it posts. Free to start.
Start free